Azenta, Inc. (NASDAQ:AZTA) Shares Bought by Kayne Anderson Rudnick Investment Management LLC

Kayne Anderson Rudnick Investment Management LLC grew its holdings in shares of Azenta, Inc. (NASDAQ:AZTAFree Report) by 1.9% during the second quarter, HoldingsChannel reports. The firm owned 5,298,040 shares of the company’s stock after purchasing an additional 100,826 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned 0.10% of Azenta worth $278,783,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the business. Hantz Financial Services Inc. acquired a new stake in Azenta in the 2nd quarter worth about $30,000. Principal Securities Inc. purchased a new stake in Azenta in the fourth quarter valued at approximately $36,000. Benjamin F. Edwards & Company Inc. acquired a new position in Azenta during the first quarter worth approximately $38,000. BI Asset Management Fondsmaeglerselskab A S purchased a new position in Azenta during the first quarter worth approximately $49,000. Finally, Lazard Asset Management LLC acquired a new position in shares of Azenta in the 1st quarter valued at $130,000. Institutional investors and hedge funds own 99.08% of the company’s stock.

Analyst Upgrades and Downgrades

AZTA has been the subject of a number of research analyst reports. Needham & Company LLC restated a “buy” rating and set a $69.00 price objective on shares of Azenta in a report on Wednesday, August 7th. Evercore ISI upped their price target on Azenta from $52.00 to $53.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 2nd. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Azenta currently has an average rating of “Hold” and a consensus target price of $67.00.

View Our Latest Analysis on AZTA

Azenta Stock Down 0.5 %

Azenta stock opened at $49.27 on Friday. The firm has a fifty day moving average of $52.36 and a 200-day moving average of $54.01. Azenta, Inc. has a 52-week low of $44.00 and a 52-week high of $69.16. The firm has a market capitalization of $2.66 billion, a P/E ratio of -18.18 and a beta of 1.47.

Azenta (NASDAQ:AZTAGet Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.07 by $0.09. Azenta had a negative net margin of 23.66% and a positive return on equity of 0.89%. The firm had revenue of $173.00 million during the quarter, compared to analysts’ expectations of $166.14 million. During the same period in the prior year, the company earned $0.13 EPS. The firm’s revenue was up 4.2% on a year-over-year basis. On average, research analysts expect that Azenta, Inc. will post 0.33 EPS for the current fiscal year.

About Azenta

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Featured Articles

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTAFree Report).

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.